한글목차

콜로이드 금 진단 키트 세계 시장 잠재력은 병원 및 클리닉 시장에서의 기회로 인해 유망합니다. 세계 콜로이드 금 진단 키트 시장은 2025년부터 2031년까지 7.2%의 연평균 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 감염성 질환의 증가, 질병의 조기 발견에 대한 관심 증가, 가정 내 검사 솔루션에 대한 선호도 증가입니다.

• Lucintel은 유형별로는 COVID-19 검출이 예측 기간 동안 높은 성장세를 보일 것으로 예상하고 있습니다.
• 용도별로는 병원이 더 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.

콜로이드 금 진단 키트 시장의 새로운 동향

콜로이드 금 진단 키트 시장은 기술 발전과 의료 수요의 변화에 영향을 받아 빠르게 진화하고 있습니다. 새로운 트렌드가 진단의 미래를 형성하고 있으며, 접근성, 효율성, 디지털 기술과의 통합에 중점을 두고 있습니다. 이러한 트렌드를 파악하는 것은 시장 역학에 부합하고 현대의 헬스케어 과제에 효과적으로 대응하고자 하는 이해관계자들에게 매우 중요합니다.

• 디지털 헬스 플랫폼과의 통합 : 콜로이드 골드 진단 키트와 디지털 헬스 플랫폼의 융합은 환자 모니터링 및 데이터 관리에 혁명을 일으키고 있습니다. 검사 키트를 모바일 애플리케이션에 연결하면 환자와 의료 서비스 제공자는 실시간으로 건강 지표를 추적할 수 있어 적시에 개입하고 개인화된 치료 계획을 수립할 수 있습니다. 이러한 통합은 환자와의 소통을 강화하고 원격의료 서비스 제공에 도움을 줄 수 있습니다.
• 다중 검사 기능 개발 : 콜로이드 골드 기술의 발전으로 여러 바이오마커를 동시에 검출할 수 있는 멀티플렉스 검사 키트가 개발되었습니다. 이 기술 혁신은 진단 과정을 간소화하여 하나의 샘플로 종합적인 건강 평가를 할 수 있게 되었습니다. 멀티플렉스 검사는 만성질환 관리 및 중복 감염 모니터링에 특히 효과적이며, 임상적 의사결정과 환자 결과를 개선할 수 있습니다.
• 환경 지속가능성 중시 : 진단 업계는 점점 더 환경 지속가능성을 우선시하고 있으며, 이는 환경 친화적인 콜로이드 금 진단 키트의 개발로 이어지고 있습니다. 제조업체들은 금 나노입자의 녹색 합성 방법을 채택하고 검사 키트의 구성요소에 생분해성 재료를 사용하고 있습니다. 이러한 변화는 환경 발자국을 줄일 뿐만 아니라, 환경 친화적인 소비자에게 어필할 수 있고, 세계 지속가능성 목표에 부합합니다.
• 동물용 진단약으로 확대 : 콜로이드 골드 진단 키트의 용도는 인간 건강 관리에만 국한되지 않고 수의학으로 확대되고 있습니다. 이 키트는 다양한 동물 질병에 대한 신속하고 정확한 검사를 제공하여 적시에 치료하고 발병 원인을 억제하는 데 도움이 됩니다. 사용 편의성과 빠른 결과는 수의사에게 귀중한 도구가 되어 동물의 건강 관리를 강화하고 축산업을 지원하고 있습니다.
• 맞춤형 의료를 위한 맞춤화 : 맞춤형 의료가 주목받으면서 콜로이드 골드 진단 키트는 특정 유전자 마커를 검출하도록 맞춤화 되고 있습니다. 이러한 맞춤화를 통해 정확한 진단과 표적 치료가 가능해져 치료 효과를 높일 수 있습니다. 진단을 개인의 유전자 프로필에 맞추는 것은 의료 서비스 제공자가 개별화된 치료를 제공함으로써 환자 만족도와 치료 결과를 향상시킬 수 있습니다.

이러한 새로운 트렌드는 기능성, 지속가능성, 다양한 분야로의 적용 가능성을 높여 콜로이드 골드 진단 키트 시장을 재편하고 있습니다. 디지털 기술의 통합, 멀티플렉스 기능의 개발, 환경적 지속가능성에 대한 강조, 동물용 진단으로의 확장, 맞춤형 의료를 위한 맞춤화 등은 전반적으로 보다 신속하고 다양한 진단의 전망에 기여하고 있습니다. 이러한 트렌드를 수용하는 이해관계자들은 진화하는 의료 수요에 대응하고 의료 진단의 미래를 주도할 수 있는 좋은 위치에 있습니다.

콜로이드 금 진단 키트 시장의 최근 동향

콜로이드 금 진단 키트 시장은 기술, 규제 당국의 승인 및 시장 확대에 있어 괄목할만한 발전을 이루었습니다. 업계는 정확도 향상, 경제성, 적용 범위의 다양성에 초점을 맞추고 있습니다. 다음은 시장에 영향을 미치는 5 가지 주요 발전입니다.

• 민감도를 높이는 첨단 나노기술 : 새로운 나노물질이 검사 민감도를 향상시켜 질병을 보다 빠르고 정확하게 감지할 수 있게 해줍니다.
• 새로운 애플리케이션에 대한 규제 당국의 승인 : 세계보건기구는 COVID-19 외에도 결핵, 말라리아, 심장 마커 등 다양한 질병에 대한 콜로이드 골드 진단 키트를 승인했습니다.
• 재택 검사 확대 : 가정용 진단 키트에 대한 수요가 증가하고 있으며, 사용자 친화적이고 휴대 가능한 검사 솔루션의 개발이 진행되고 있습니다.
• 전략적 제휴 및 합병 : 연구 역량 강화, 판매 채널 확대, 신시장 진입을 위해 각 사가 제휴를 맺고 있습니다.
• 신흥시장에서의 성장 : 신흥국 시장에서는 저렴한 가격과 사용 편의성으로 인해 콜로이드 금 진단키트가 빠르게 보급되고 있으며, 시장 성장의 원동력이 되고 있습니다.

이러한 개발은 콜로이드 금 진단 키트 시장의 성장을 가속화하고 있으며, 전 세계적으로 접근성과 진단 효율성을 향상시키고 있습니다.

목차

제1장 주요 요약

제2장 세계의 콜로이드 금 진단 키트 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 콜로이드 금 진단 키트 시장 동향(2019-2024년)과 예측(2025-2031년)
• 유형별
  • COVID-19 검출
  • SARS-CoV 검출
  • 기타
• 용도별
  • 병원
  • 클리닉
  • 기타

제4장 2019년부터 2031년까지 지역별 시장 동향과 예측 분석

• 지역별
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별
  • 용도별
  • 지역별
• 세계의 콜로이드 금 진단 키트 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 콜로이드 금 진단 키트 시장 능력 확대
  • 세계의 콜로이드 금 진단 키트 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Abbott
• Zybio
• DCN Diagnostics
• RayBiotech
• InTec
• Goldsite
• Tailin
• ADS Biotec
• Sansure Biotech
• AMPER

영문목차

The future of the global colloidal gold diagnostic test kit market looks promising with opportunities in the hospital and clinic markets. The global colloidal gold diagnostic test kit market is expected to grow with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the increasing prevalence of infectious diseases, the rising focus on early disease detection, and the increasing preference for home testing solutions.

• Lucintel forecasts that, within the type category, COVID-19 detection is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness the higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Colloidal Gold Diagnostic Test Kit Market

The colloidal gold diagnostic test kit market is evolving rapidly, influenced by technological advancements and changing healthcare needs. Emerging trends are shaping the future of diagnostics, focusing on accessibility, efficiency, and integration with digital technologies. Identifying these trends is crucial for stakeholders aiming to align with market dynamics and address contemporary healthcare challenges effectively.

• Integration with Digital Health Platforms: The convergence of colloidal gold diagnostic kits with digital health platforms is revolutionizing patient monitoring and data management. By connecting test kits to mobile applications, patients and healthcare providers can track health metrics in real-time, facilitating timely interventions and personalized care plans. This integration enhances patient engagement and supports remote healthcare delivery, aligning with the growing trend of telemedicine.
• Development of Multiplex Testing Capabilities: Advancements in colloidal gold technology have led to the creation of multiplex test kits capable of detecting multiple biomarkers simultaneously. This innovation streamlines the diagnostic process, allowing for comprehensive health assessments from a single sample. Multiplex testing is particularly beneficial in managing chronic diseases and monitoring co-infections, improving clinical decision-making and patient outcomes.
• Focus on Environmental Sustainability: The diagnostic industry is increasingly prioritizing environmental sustainability, leading to the development of eco-friendly colloidal gold test kits. Manufacturers are adopting green synthesis methods for gold nanoparticles and utilizing biodegradable materials in test kit components. This shift not only reduces the environmental footprint but also appeals to environmentally conscious consumers and aligns with global sustainability goals.
• Expansion into Veterinary Diagnostics: The application of colloidal gold diagnostic kits is expanding beyond human healthcare into veterinary medicine. These kits offer rapid and accurate testing for various animal diseases, aiding in timely treatment and control of outbreaks. The ease of use and quick results make them valuable tools for veterinarians, enhancing animal health management and supporting the livestock industry.
• Customization for Personalized Medicine: Personalized medicine is gaining prominence, and colloidal gold diagnostic kits are being tailored to detect specific genetic markers. This customization enables precise diagnostics and targeted therapies, improving treatment efficacy. By aligning diagnostics with individual genetic profiles, healthcare providers can offer personalized care, enhancing patient satisfaction and outcomes.

These emerging trends are reshaping the colloidal gold diagnostic test kit market by enhancing functionality, sustainability, and applicability across various sectors. The integration of digital technologies, development of multiplex capabilities, focus on environmental sustainability, expansion into veterinary diagnostics, and customization for personalized medicine collectively contribute to a more responsive and versatile diagnostic landscape. Stakeholders embracing these trends are well-positioned to meet evolving healthcare demands and drive the future of medical diagnostics.

Recent Developments in the Colloidal Gold Diagnostic Test Kit Market

The colloidal gold diagnostic test kit market has witnessed notable developments in technology, regulatory approvals, and market expansion. The industry is focusing on increasing accuracy, affordability, and application diversity. Below are five key developments influencing the market.

• Advanced Nanotechnology for Enhanced Sensitivity: New nanomaterials are improving test sensitivity, enabling earlier and more precise disease detection.
• Regulatory Approvals for New Applications: Global health agencies are approving colloidal gold test kits for various diseases beyond COVID-19, such as tuberculosis, malaria, and cardiac markers.
• Expansion of Home-Based Testing: The demand for at-home diagnostic kits is increasing, leading to the development of user-friendly and portable test solutions.
• Strategic Partnerships and Mergers: Companies are forming alliances to enhance research capabilities, expand distribution channels, and enter new markets.
• Growth in Emerging Markets: Developing nations are rapidly adopting colloidal gold test kits due to their affordability and ease of use, driving market growth.

These developments are accelerating the growth of the colloidal gold diagnostic test kit market, improving accessibility and diagnostic efficiency worldwide.

Strategic Growth Opportunities in the Colloidal Gold Diagnostic Test Kit Market

Growth opportunities in the colloidal gold diagnostic test kit market are driven by advancements in technology and expanding applications. Below are five key opportunities for market expansion.

• Point-of-Care Testing Expansion: Increased demand for decentralized testing is driving innovation in rapid and portable diagnostic kits.
• Chronic Disease Monitoring: The rise in chronic conditions like diabetes and cardiovascular diseases presents an opportunity for long-term diagnostic solutions.
• Developing Markets Expansion: Emerging economies are experiencing high demand due to improved healthcare access and affordability of test kits.
• Integration with Wearable Health Devices: Connecting test kits with wearable sensors allows for continuous health monitoring and personalized treatment plans.
• Research and Development in Oncology Diagnostics: Companies are investing in colloidal gold test kits for cancer biomarker detection, improving early diagnosis.

Conclusion: These strategic opportunities are shaping the future of the colloidal gold diagnostic test kit market by enhancing accessibility, affordability, and innovation.

Colloidal Gold Diagnostic Test Kit Market Driver and Challenges

The colloidal gold diagnostic test kit market is influenced by several technological, economic, and regulatory factors. Key drivers such as increasing demand for rapid testing, advancements in nanotechnology, and expanding healthcare access are pushing market growth. However, challenges like regulatory hurdles, competition from alternative technologies, and quality control concerns pose constraints. Understanding these factors is essential for stakeholders to navigate market dynamics effectively.

The factors responsible for driving the colloidal gold diagnostic test kit market include:

1. Rising Demand for Rapid and Point-of-Care Testing: The need for quick and convenient diagnostic solutions is driving demand for colloidal gold test kits. These kits offer fast results, making them ideal for emergency settings and remote healthcare facilities. Their ease of use and affordability further enhance their adoption in both developed and developing regions.

2. Advancements in Nanotechnology: Continuous improvements in nanotechnology are enhancing the sensitivity and accuracy of colloidal gold diagnostic kits. The use of advanced nanoparticles ensures better detection rates, even at low antigen concentrations. This technological advancement expands the range of applications and improves diagnostic reliability.

3. Growing Prevalence of Infectious Diseases: The global rise in infectious diseases, including COVID-19, influenza, and malaria, has increased the demand for reliable and quick diagnostic solutions. Colloidal gold test kits are particularly effective for mass screening and are extensively used in hospitals, clinics, and home-based testing scenarios.

4. Government Support and Health Initiatives: Governments worldwide are investing in healthcare infrastructure and promoting the use of rapid diagnostic kits to ensure early disease detection and prevention. Subsidies and approval for colloidal gold test kits are enabling broader market penetration and enhancing public health outcomes.

5. Expansion into Emerging Markets: Emerging economies are witnessing significant growth in the adoption of colloidal gold diagnostic test kits due to increased healthcare investments and improved accessibility. These markets offer lucrative opportunities for manufacturers aiming to expand their global footprint.

Challenges in the colloidal gold diagnostic test kit market are:

1. Stringent Regulatory Requirements: Obtaining regulatory approvals for diagnostic test kits is complex and time-consuming. Compliance with global standards requires rigorous testing and documentation, which can delay market entry and increase production costs.

2. Competition from Alternative Technologies: Emerging diagnostic technologies, such as PCR and ELISA tests, offer higher accuracy and sensitivity. This creates competition and limits the market share for colloidal gold test kits, especially in specialized diagnostic applications.

3. Quality Control and Consistency Issues: Maintaining consistent quality in large-scale production can be challenging. Variability in test kit performance may lead to inaccurate results, reducing consumer trust and hindering market growth. Manufacturers need to invest in stringent quality assurance processes to overcome this challenge.

The colloidal gold diagnostic test kit market is growing, driven by factors like rising demand for rapid diagnostics, technological advancements, and expanding healthcare access. However, challenges such as regulatory complexities, competition from alternative methods, and quality control concerns need to be addressed to ensure sustainable growth. Companies that focus on innovation, regulatory compliance, and quality assurance are likely to succeed in this evolving market landscape.

List of Colloidal Gold Diagnostic Test Kit Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colloidal gold diagnostic test kit companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colloidal gold diagnostic test kit companies profiled in this report include-

• Abbott
• Zybio
• DCN Diagnostics
• RayBiotech
• InTec
• Goldsite
• Tailin
• ADS Biotec
• Sansure Biotech
• AMPER

Colloidal Gold Diagnostic Test Kit Market by Segment

The study includes a forecast for the global colloidal gold diagnostic test kit market by type, application, and region.

Colloidal Gold Diagnostic Test Kit Market by Type [Value from 2019 to 2031]:

• COVID-19 Detection
• SARS-CoV Detection
• Others

Colloidal Gold Diagnostic Test Kit Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

Colloidal Gold Diagnostic Test Kit Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Colloidal Gold Diagnostic Test Kit Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below image highlights recent developments by major colloidal gold diagnostic test kit producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the United States, the colloidal gold diagnostic test kit market has seen substantial advancements, particularly in the realm of point-of-care testing. The COVID-19 pandemic underscored the necessity for rapid diagnostics, leading to widespread adoption of colloidal gold-based rapid antigen tests. Regulatory bodies like the FDA granted emergency use authorizations for these kits, expediting their deployment. Moreover, collaborations between biotech firms and research institutions have fostered innovation, resulting in test kits with enhanced sensitivity and specificity. The emphasis on home-based testing has also surged, aligning with the public's preference for convenient and immediate healthcare solutions.
• China: China's colloidal gold diagnostic test kit market has experienced rapid expansion, driven by technological innovation and government support. The country's robust manufacturing capabilities have enabled mass production of these kits, ensuring affordability and accessibility. During the pandemic, Chinese companies swiftly developed and distributed colloidal gold-based COVID-19 test kits, both domestically and internationally. The integration of advanced nanotechnology has improved test accuracy, while strategic partnerships with global health organizations have bolstered credibility. China's focus on strengthening its healthcare infrastructure continues to propel the market forward.
• Germany: Germany has made notable strides in the colloidal gold diagnostic test kit market, emphasizing precision and quality. German companies have invested in research to enhance the sensitivity of these kits, catering to various medical conditions beyond infectious diseases, such as cardiac markers and tumor detection. The country's stringent regulatory standards ensure the reliability of these diagnostic tools. Collaborations between industry and academic institutions have facilitated the development of innovative solutions, reinforcing Germany's position as a leader in medical diagnostics.
• India: In India, the colloidal gold diagnostic test kit market has grown significantly, primarily due to the demand for cost-effective and rapid diagnostic solutions. Local manufacturers have risen to the challenge, producing affordable test kits suitable for diverse healthcare settings, including rural areas. The government's initiatives to promote indigenous production and reduce dependency on imports have further stimulated market growth. Additionally, public-private partnerships have been instrumental in scaling up production and distribution, ensuring wider reach and impact.
• Japan: Japan's colloidal gold diagnostic test kit market is characterized by technological sophistication and a focus on innovation. Japanese companies have integrated advanced nanomaterials to improve test performance, achieving higher sensitivity and faster results. The aging population has driven the demand for convenient diagnostic tools, leading to the development of user-friendly home testing kits. Collaborations with international research bodies have expanded the applications of these kits, addressing a broader spectrum of diseases and enhancing Japan's contribution to global healthcare advancements.

Features of the Global Colloidal Gold Diagnostic Test Kit Market

Market Size Estimates: Colloidal gold diagnostic test kit market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Colloidal gold diagnostic test kit market size by type, application, and region in terms of value ($B).

Regional Analysis: Colloidal gold diagnostic test kit market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the colloidal gold diagnostic test kit market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colloidal gold diagnostic test kit market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the colloidal gold diagnostic test kit market by type (COVID-19 detection, SARS-CoV detection, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colloidal Gold Diagnostic Test Kit Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Colloidal Gold Diagnostic Test Kit Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Colloidal Gold Diagnostic Test Kit Market by Type
  • 3.3.1: COVID-19 Detection
  • 3.3.2: SARS-CoV Detection
  • 3.3.3: Others
• 3.4: Global Colloidal Gold Diagnostic Test Kit Market by Application
  • 3.4.1: Hospital
  • 3.4.2: Clinic
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Colloidal Gold Diagnostic Test Kit Market by Region
• 4.2: North American Colloidal Gold Diagnostic Test Kit Market
  • 4.2.1: North American Market by Type: COVID-19 Detection, SARS-CoV Detection, and Others
  • 4.2.2: North American Market by Application: Hospital, Clinic, and Others
• 4.3: European Colloidal Gold Diagnostic Test Kit Market
  • 4.3.1: European Market by Type: COVID-19 Detection, SARS-CoV Detection, and Others
  • 4.3.2: European Market by Application: Hospital, Clinic, and Others
• 4.4: APAC Colloidal Gold Diagnostic Test Kit Market
  • 4.4.1: APAC Market by Type: COVID-19 Detection, SARS-CoV Detection, and Others
  • 4.4.2: APAC Market by Application: Hospital, Clinic, and Others
• 4.5: ROW Colloidal Gold Diagnostic Test Kit Market
  • 4.5.1: ROW Market by Type: COVID-19 Detection, SARS-CoV Detection, and Others
  • 4.5.2: ROW Market by Application: Hospital, Clinic, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Colloidal Gold Diagnostic Test Kit Market by Type
  • 6.1.2: Growth Opportunities for the Global Colloidal Gold Diagnostic Test Kit Market by Application
  • 6.1.3: Growth Opportunities for the Global Colloidal Gold Diagnostic Test Kit Market by Region
• 6.2: Emerging Trends in the Global Colloidal Gold Diagnostic Test Kit Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Colloidal Gold Diagnostic Test Kit Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colloidal Gold Diagnostic Test Kit Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: Zybio
• 7.3: DCN Diagnostics
• 7.4: RayBiotech
• 7.5: InTec
• 7.6: Goldsite
• 7.7: Tailin
• 7.8: ADS Biotec
• 7.9: Sansure Biotech
• 7.10: AMPER